Unlocking Commercial Access in Switzerland

Your trusted partner for pharmaceuticals, medical devices, and diagnostics.

Why Choose Us

Discover How Imunaris is Transforming Commercial Access in Switzerland

imunaris is a forward-thinking Swiss startup committed to facilitating commercial access for pharmaceuticals, medical devices, and diagnostics. With a focus on agile and efficient methods, we offer tailored solutions to conquer the complexities of the Swiss healthcare market.

As your dedicated partner, imunaris specializes in helping businesses navigate product commercialization, particularly in the fields of vaccines, pediatrics, and dermatology, ensuring their success in Switzerland.

2 national cancer institute zeitggtlwzi unsplash

Meet Our FounderS

imunaris Team

The imunaris Team is composed of experienced professionals with a passion for transforming healthcare accessibility. Our combined expertise allows us to provide innovative strategies that drive success for our clients in a competitive environment.

The owners and founders were inspired to launch imunaris after recognizing the challenges faced by international companies in accessing the Swiss market, motivating a passion for streamlining the commercialization process.

Daniel Fässler

Chief Executive Officer

With over 20 years of strategic leadership across the pharmaceutical and biotech industries and an MBA from the University of Rochester, Daniel brings deep expertise in commercial strategy, portfolio optimization, and global health impact. Throughout his career at leading pharmaceutical companies including Takeda, Novartis, and GSK, Daniel has consistently delivered impactful results in complex global environments. His achievements include establishing Centers of Excellence for data-driven decision-making, leading commercial assessments for strategic M&A transactions, and successfully launching specialized vaccines across multiple markets. He has shaped go-to-market strategies for critical health solutions, from dengue vaccines to pediatric immunizations, consistently optimizing resource allocation to maximize both commercial success and patient access.

Expertise & Qualifications

MBA – University of Rochester (William E. Simon Graduate School)
20+ years strategic leadership in pharmaceutical and biotech industries
Expert in Commercial Operations, Analytics Excellence, and Market Access
Proven track record in M&A assessments and portfolio optimization
Background in Chemistry and Informatics
Extensive experience in vaccines, pediatrics, and specialty pharmaceuticals

LinkedIn Profile

Dr. Eckhardt Petri

Chief Medical Officer

Dr. Petri brings over two decades of experience in the pharmaceutical industry with specialization in Global Medical Affairs and Public Health. With his PhD in Tumor Immunology and Master of Health Business Administration (MHBA), he combines scientific excellence with strategic business understanding. At Takeda, he led international medical strategies as Senior Director Global Medical Affairs and fostered Key Opinion Leader engagement. His expertise spans Phase IV studies, infectious disease diagnostics, and international health initiatives.

Expertise & Qualifications

Dr. rer. physiol. (PhD) – Tumor Immunology, University of Tübingen
MHBA – Health Business Administration, University of Erlangen-Nürnberg
Launch experience vaccines & diagnostics
25+ years pharma & diagnostics experience (Takeda, Roche, Seqirus, Novartis, Dade Behring)
Expert in Global Medical Affairs and Public Health

LinkedIn Profile

Take the Next Step

Connect with us to explore tailored solutions for your business.

Get Started Now